Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 114.50
Bid: 116.00
Ask: 121.50
Change: 0.00 (0.00%)
Spread: 5.50 (4.741%)
Open: 114.50
High: 114.50
Low: 114.50
Prev. Close: 114.50
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Aug 2023 07:00

RNS Number : 0903I
Xaar PLC
03 August 2023
 

3 August 2023

 

Xaar plc

 

TRADING UPDATE

 

Xaar plc ("Xaar" or "the Group"), the leading inkjet printing technology group, today announces a trading update for the six months ended 30 June 2023.

 

TRADING

 

Continued strong trading - in line with expectations

 

· Revenue for the period anticipated to be £34.7 million (H1 2022: £36.6 million).

· Adjusted profit before tax in line with management expectations, with the impact of the successful factory re-organisation offset by the planned sale of £1.8 million of non-core IP assets.

 

Further strategic and operational progress

 

· Increasing number of customers developing products using Aquinox with product launches expected in H2 2023.

· Commercial partnership with Quantica announced on 5 July 2023 enhances the Group's position in leading the market in printing highly viscous fluids.

· Phase one of factory efficiency programme completed on time and within budget.

· Product Print Systems business ("EPS") delivered a strong performance in the period with both revenue and margin growth.

 

 

BALANCE SHEET

 

The Group remains well capitalised with a strong balance sheet and with a net cash position as at 30 June 2023 of £7.3 million (30 June 2022: £12.6 million) in line with management expectations, reflecting the previously communicated investment in inventory predominantly in H2 2022.

 

 

OUTLOOK

 

· Market conditions expected to improve further in China in H2 and coupled with increased customer product launches will increase demand for Xaar printheads.

· Our strategy to diversify across a range of market sectors means further product launches are expected in 2024 providing confidence in delivering our mid-term growth plans.

· Previous investment in inventory holding means the Group is well placed to capitalise on further commercial opportunities.

· While remaining vigilant to broader macroeconomic conditions the Board continues to expect to deliver its expectations for the full year.

 

 

John Mills, Chief Executive Officer, commented:

 

"We remain focused on the delivery of our strategy and taking advantage of the significant opportunities we have that will drive profitable growth. Our products continue to generate strong interest from customers, demonstrating our leadership in printing highly viscous fluids with all the sustainability benefits they can deliver. We have positive momentum, a growing product pipeline and look forward to continuing to accelerate our strategy and performance in H2 and into 2024."

 

 

 

Note: Adjusted profit before tax is profit before tax excluding the impact of share-based payment charges, exchange differences relating to intra-group transactions, gain on derivative financial instruments, restructuring and transaction expenses, research and development expenditure credit, fair value gain on financial assets at fair value through profit and loss, and amortisation of acquired intangible assets.

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

Teneo

+44 (0) 207 353 4200

Giles Kernick

Olivia Lucas

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKBBBDBKDPFK
Date   Source Headline
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights
24th Apr 20231:05 pmRNSAnnual Financial Report
3rd Apr 20234:51 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.